Syngenta Scientist: Eureka! Atrazine Doesn’t Cause Cancer

An herbicide applicator in action. Photo courtesy of Syngenta

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


As I reported a while back, sales of atrazine—a potent herbicide popular among large-scale corn farmers—are booming. That’s good news for atrazine-maker Syngenta, the globe’s largest pesticide company; and bad news for all ecosytems (including human ones) in and downstream from the places where farmers apply the nasty stuff.

The case against atrazine has gotten so strong that the EPA is actively considering joining the European Union in banning it. The EPA announced its review of atrazine in 2009 and suggested the process would take a year. In late July, the EPA committee overseeing the review met toi compare notes. An EPA press officer told me at the time it would be “upwards of 90 days” before the agency announced any decision.

Predictably enough, Syngenta is taking advantage of the slow-motion review to do what it did last time the EPA looked anew at the toxicology of atrazine, which was back in 2003: It’s funding research that exonerates its cash-cow herbicide and submitting it to the EPA. That tactic worked in ‘03, even though the Syngenta-bought research turned out to be pretty shoddy.

Pesticide Action Network’s Ground Truth blog points out that not long before the EPA’s July meeting, a team led by Syngenta employee Charles B. Breckenridge submitted a study claiming to show that atrazine isn’t linked to breast cancer, despite much evidence to the contrary. As the Physicians for Social Responsibility put it in a recent letter (PDF) to the EPA:

Several scientific studies have found a link between long-term exposure to atrazine and breast cancer. A study of women from all 120 counties of Kentucky showed a statistically significant increase in breast cancer risk with medium and high levels of atrazine exposure. A study from UK found a significant association between breast cancer rates and the application of atrazine in rural Leicestershire. Other studies using lab rats as subjects found exposure to atrazine increased risks of breast and prostrate cancers.

Surely, the EPA will heed the vast weight of independent research and train a skeptical eye on the company-funded stuff. Right? Pesticide Action Network isn’t sure. “Are we worried”? the group’s blog post asks. “Unfortunately, yes.”

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate